ctrl K

Mangoceuticals Inc. (MGRX)

NASDAQ: MGRX · Real-Time Price · USD

1.63

-0.03 (-1.81%)

At close: May 01, 2025, 3:59 PM

1.62

-0.64%

Pre-market: May 02, 2025, 06:18 AM EDT

Mangoceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	58.65K	739.01K	682.86K	22.55K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	16.94K	16.94K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	18.5K	n/a	n/a
Other Current Assets	16.94K	n/a	n/a	n/a
Total Current Assets	75.59K	818.46K	694.61K	22.55K
Property-Plant & Equipment	62.3K	215.39K	291.74K	n/a
Goodwill & Intangibles	15.23M	n/a	n/a	n/a
Total Long-Term Assets	15.29M	232.33K	308.68K	n/a
Total Assets	15.37M	1.05M	1M	22.55K
Account Payables	837.5K	140.76K	33.67K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	214.96K	n/a	167.46K	39.27K
Other Current Liabilities	373K	n/a	n/a	n/a
Total Current Liabilities	1.43M	211.08K	260.58K	39.27K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	64.96K	128.68K	n/a
Total Liabilities	1.43M	276.04K	389.26K	39.27K
Total Debt	214.96K	128.68K	352.87K	39.27K
Common Stock	325.00	2.14K	1.34K	800.00
Retained Earnings	-20.81M	-11.23M	-2.02M	-17.7K
Comprehensive Income	-9.85K	n/a	0.00	0.00
Shareholders Equity	13.95M	774.75K	614.03K	-16.72K
Total Investments	n/a	n/a	n/a	n/a